Full Episode
Saturday, Sep 6
PBS NewsHour
  • Episodes
  • Podcasts
  • Newsletters
  • The Latest
  • Politics
    Politics
    • Brooks and Capehart
    • Politics Monday
    • Supreme Court
  • Arts
    Arts
    • CANVAS
    • Poetry
    • Now Read This
  • Nation
    Nation
    • Supreme Court
    • Race Matters
    • Essays
    • Brief But Spectacular
  • World
    World
    • Agents for Change
  • Economy
    Economy
    • Making Sen$e
    • Paul Solman
  • Science
    Science
    • The Leading Edge
    • ScienceScope
    • Basic Research
    • Innovation and Invention
  • Health
    Health
    • Long-Term Care
  • Education
    Education
    • Teachers' Lounge
    • Student Reporting Labs
  • For Teachers
    Education
    • Newshour Classroom
  • About
    • Feedback
    • Funders
    • Support
    • Jobs

We're not going anywhere.

Stand up for truly independent, trusted news that you can count on!
Donate now
PBS News

Get news alerts from PBS News

Turn on desktop notifications?

Julie Appleby, Kaiser Health News

  • Full Episodes
  • Podcasts
  • Newsletters
  • Live

About Julie @Julie_Appleby

Julie Appleby reports on the health care law's implementation, health care treatments and costs, trends in health insurance, and policy affecting hospitals and other medical providers for Kaiser Health News.

Julie’s Recent Stories

Health Dec 02

Health law’s experiment that tests new ways to pay for care could offer tool for GOP ideas

Economists and policymakers think the U.S. may be overpaying for many medical services, and the health law has a program to test that. But with the ACA up for potential repeal, what happens to that testing now? One of the…

Health Oct 05

Prostate cancer patients are paying hefty price for controversial new treatment

Men hoping to avoid some side effects of prostate cancer treatment are shelling out tens of thousands of dollars for a procedure whose long-term effects are unknown and insurers, including Medicare, won’t pay for.

Health Sep 15

The ads say, ‘Get your flu shot today,’ but it may be wiser to wait

The start of flu season is still weeks — if not months — away. Yet marketing of the flu shot has become an almost year-round effort.

Health Sep 01

Mylan’s generic EpiPen — a price break or marketing maneuver?

Following weeks of criticism, Mylan said Monday it will offer a generic version of its life-saving allergy treatment, the EpiPen. But what does this development mean for consumers and the marketplace?…

Health Aug 01

Opioid dependence leads to ‘tsunami’ of medical services, study finds

In one of the first looks at privately insured patients with opioid problems, researchers paint a grim picture: Medical services for people with opioid dependence diagnoses skyrocketed more than 3,000 percent between 2007 and 2014.

Health May 25

Could Medicare’s drug pricing plan give regulators too much power?

The aim, the government says, is to maintain quality while slowing spending in Medicare Part B by more closely tying payments to how well drugs work, using methods drugmakers, insurers and benefit managers are already trying in the private sector.

Health May 17

Feds cap how much sensitive medical data employers can collect through wellness programs

Employer wellness programs can gather medical information from employees and spouses — so long as financial incentives or penalties don’t exceed 30 percent of the annual cost for an individual in the company’s group health plan, according to final rules issued…

Health Dec 21

Why health plans’ drug coverage can be confusing for consumers

Patients getting chemotherapy or other complex medications may have a sudden panic when shopping for health insurance: Their drugs often don’t appear to be covered.

Health Oct 19

Why some prescription drugs are so expensive

The news last month that Turing Pharmaceuticals had raised the price of a drug by 5,000 percent renewed a public conversation about how drug prices are set in the U.S.

Health Sep 14

These new heart failure treatments show promise, but at a huge price

Two new treatments for congestive heart failure cost too much in the short term and would drive up spending by insurers and government programs, a nonprofit group said in an analysis released Friday, just days after the same researchers took…

Jump to the First Page Previous Page
1 2 3
Next Page Jump to the Last Page

Support Provided By: Learn more

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

PBS News

© 1996 - 2025 NewsHour Productions LLC. All Rights Reserved.

PBS is a 501(c)(3) not-for-profit organization.

Sections

  • The Latest
  • Politics
  • Arts
  • Nation
  • World
  • Economy
  • Science
  • Health
  • Education

About

  • About Us
  • TV Schedule
  • Press
  • Feedback
  • Funders
  • Support
  • Newsletters
  • Podcasts
  • Jobs
  • Privacy
  • Terms of Use

Stay Connected

  • Facebook
  • YouTube
  • Instagram
  • X
  • TikTok
  • Threads
  • RSS

Subscribe to Here's the Deal with Lisa Desjardins

Form error message goes here.

Thank you. Please check your inbox to confirm.

Support our journalism

Support for News Hour Provided By

  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You